Company Monitoring Page for Shire

latest headlines for company on cafepharma

Can Baxalta hold off Shire with its own bid for Ariad?
Fierce Pharma
Mon, 08/31/15 - 11:20 am
Tags:
Baxalta, Shire, M&A, Ariad Pharmaceuticals
Who should Allergan buy next?
Fierce Pharma
Tue, 08/25/15 - 02:10 pm
Tags:
Allergan, M&A, AbbVie, Shire, Amgen, Biogen
Baxalta CEO touts new R&D model with a focus on development
BioPharma Dive
Fri, 08/21/15 - 11:01 am
Tags:
Baxalta, R&D, Shire
Vyvanse set to steal ADHD share in back-to-school meds rush
Fierce Pharma Marketing
Wed, 08/19/15 - 12:17 pm
Tags:
ADHD, Vyvanse, Shire, JNJ, Concerta
The 5 Most Expensive Drugs in the World in 2015
Motley Fool
Sun, 08/16/15 - 10:32 am
Tags:
drug pricing, Glybera, Soliris, Naglazyme, Vimizim, Elaprase, Shire, Biomarin, Alexion, uniQure
Shire seen having wiggle room on price in $30 bln Baxalta battle
Yahoo/Reuters
Thu, 08/13/15 - 10:43 am
Tags:
Shire, Baxalta, M&A
Here Is Why Baxalta Inc (BXLT) And Shire PLC (ADR) (SHPG) Declined Yesterday
Bidness, ETC
Wed, 08/12/15 - 08:50 am
Tags:
Baxalta, Shire, M&A
Baxalta's not swayed by Shire's 'lowball' $30B, CEO says
Fierce Biotech
Tue, 08/11/15 - 06:52 pm
Tags:
Baxalta, Shire, M&A, Pharma CEOs, Ludwig Hantson
Shire PLC (ADR) - Baxalta Inc Merger Talk, What Will Be Shire’s Next Move?
Bidness, ETC
Tue, 08/11/15 - 11:35 am
Tags:
Shire, Baxalta, M&A
[video]After Baxalta’s rejection, a bigger offer is likely needed from Shire
Bizjournals.com
Thu, 08/6/15 - 08:24 am
Tags:
Baxalta, Shire, M&A
Shire’s Baxalta bid: Poison pill or antidote?
CNBC
Wed, 08/5/15 - 09:31 am
Tags:
Shire, Baxalta, M&A, poison pill
Baxalta responds to a frustrated Shire: The answer is still 'no'
Fierce Biotech
Tue, 08/4/15 - 05:55 pm
Tags:
Shire, M&A, Baxalta
Shire Proposes Combination With Baxalta to Create the Leading Global Biotech Company Focused on Rare Diseases
Yahoo
Tue, 08/4/15 - 08:20 am
Tags:
Shire, Baxalta, M&A
Shire chief Ornskov bets $300M on another eye drug bolt-on buyout
Fierce Biotech
Mon, 08/3/15 - 08:53 am
Tags:
Shire, Flemming Ornskov, M&A, FST-100, ophthalmology
Shire CEO: We're prepared to wait for the right deal
Fierce Pharma
Fri, 07/24/15 - 03:42 pm
Tags:
Shire, Flemming Ornskov, M&A, Pharma CEOs
Shire Deepens Push Into Biotech After AbbVie Drops Bid
WSJ Online
Mon, 07/13/15 - 07:33 pm
Tags:
Shire, AbbVie, M&A
Shire's Vyvanse could bag another lucrative new market in menopausal women
Fierce Pharma Marketing
Tue, 06/16/15 - 12:11 pm
Tags:
Shire, menopause, Vyvanse
Biogen, Shire, Allergan top list of 'greenest' corporations in the world
BioPharma Dive
Thu, 06/11/15 - 11:01 am
Tags:
Allergan, Biogen, Shire, environmental concerns
Dyax's Threat to $630,000 Shire Drug Makes It a Target
Bloomberg
Thu, 06/11/15 - 10:13 am
Tags:
Shire, Dyax, DX-2930, HAE, hereditary angiodema, Cinryze
The latest Shire buyout rumor: An $18.9B bid for Actelion
Fierce Biotech
Mon, 06/8/15 - 11:17 am
Tags:
Shire, M&A, Actelion

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.